65,437 trials
Acute Kidney Injury
Primary: Adverse Events — 0 adverse event
Elbow Injury · Elbow Fracture
Primary: Pocket Sized Ultrasound Elbow Exam Interpretation of Fracture — 8; 5; 7; 6 Participants
Pancreatic Neuroendocrine Tumors
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) (All Causalities and Treatment-related) — 61; 13; 52; 12 Participants
Opioid Use
Primary: The Feasibility of Developing a Culturally Relevant Facebook Intervention — 33.0 engagement events
PTSD
Primary: The Mean Change From Baseline (Visit 2) in the Total CAPS-5 Score After 12 Weeks of Treatment Evaluated at Visit 9 (Week 12). — -17.0; -19.2; -21.5 units on a scale
Maternal Depression and Parent Practices, Postpartum · Infant Development
Primary: PHQ9 — 11.94; 10.31; 5.61; 5.33 score on a scale — p=0.503
CIPN - Chemotherapy-Induced Peripheral Neuropathy
Primary: Relative Change in % pO2 — 12.3; 19; 24; 25.3 change in % oxygenation
Addiction
Primary: Satisfaction With Life at Baseline — 17.8; 17.2 units on a scale
Hypertension
Primary: Change in Mean Systolic Blood Pressure — 142.8; 146.8; 143.9; 144.7 mmHg
Mandibular Fractures
Primary: The Time Taken to Complete an Open Reduction Internal Fixation (ORIF) — 54.6; 34 minutes
Chronic Low-Back Pain · Refractory Pain · Neuropathic Pain
Primary: The Difference in Responders Between Both Groups — 87; 5 participants — p=<0.0001
Stroke
Primary: Fugl Meyer Upper Limb Motor Assessment — 36.52 score on a scale
Ventral Hernia
Primary: Incidence of Post-operative Complications Requiring Procedural Intervention Within 90 Days Post Index Procedure — 2 Participants
Arrhythmias, Cardiac · Heart Block
Primary: Number of Participants With Difference in Detection of Clinically Significant Arrhythmias for the Zio Versus the Holter — 0 participants — p=0.23
Blood Pressure
Primary: Change From Baseline to Week 8 in Mean Systolic Blood Pressure as Measured by 24-hr ABPM — -3.3; 1.4; -0.1 mmHg — p=< 0.001